Martin Metzenmacher - Concepedia

Author

Martin Metzenmacher

University of Duisburg-Essen ORCID

Also Known As

M Metzenmacher, M. Metzenmacher, Martin Metzenmacher, Metzenmacher, Martin

Publications

830

Citations

H-Index

Concepts

All Affiliations

University of Duisburg-Essen Essen University Hospital Ruhrlandklinik Deutschen Konsortium für Translationale Krebsforschung Heidelberg University

About

Martin Metzenmacher is an author at University of Duisburg-Essen specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	364
2	Health Sciences	3	3	183
3	Immunology	3	3	176
4	Engineering	1	1	53
5	Blood Transplantation	1	1	16

Martin Metzenmacher

Publications

701

Citations

H-Index

Page 1

	Year	Citations
MET Expression in Advanced Non–Small-Cell Lung Cancer: Effect on Clinical Outcomes of Chemotherapy, Targeted Therapy, and Immunotherapy Henning Reis, Martin Metzenmacher, Moritz Goetz, Clinical Lung Cancer Met ExpressionMedicineMetronomic TherapyImmunologyClinical Outcomes	2018	106
KRAS G12C-mutated advanced non-small cell lung cancer: A real-world cohort from the German prospective, observational, nation-wide CRISP Registry (AIO-TRK-0315) Martin Sebastian, Wilfried Eberhardt, Petra Hoffknecht, Lung Cancer	2021	75
Thoracic staging with 18F-FDG PET/MR in non-small cell lung cancer – does it change therapeutic decisions in comparison to 18F-FDG PET/CT? Benedikt M. Schaarschmidt, Johannes Grueneisen, Martin Metzenmacher, European Radiology Positron Emission Tomography18F-fdg Pet/ctOncologic ImagingMedicinePet-mri	2016	64
Impact of RAS mutation subtype on clinical outcome—a cross-entity comparison of patients with advanced non-small cell lung cancer and colorectal cancer Marcel Wiesweg, Stefan Kasper, Karl Worm, Oncogene MedicinePathologyColorectal CancerRas Mutation SubtypeCancer Genomics	2018	57
Machine learning reveals a PD-L1–independent prediction of response to immunotherapy of non-small cell lung cancer by gene expression context Marcel Wiesweg, Fabian Mairinger, Henning Reis, European Journal of Cancer Systems BiologyEngineeringMachine LearningPd-l1–independent PredictionCancer Immunosurveillance	2020	53
Sarcomatoid carcinoma of the lung: a rare histological subtype of non-small cell lung cancer with a poor prognosis even at earlier tumour stages Christian Roesel, Sarah Terjung, Gerhard Weinreich, Interactive Cardiovascular and Thoracic Surgery	2016	41
Plasma Next Generation Sequencing and Droplet Digital-qPCR-Based Quantification of Circulating Cell-Free RNA for Noninvasive Early Detection of Cancer Martin Metzenmacher, Renáta Váraljai, Balázs Hegedűs, Cancers	2020	39
Machine learning-based predictors for immune checkpoint inhibitor therapy of non-small-cell lung cancer Marcel Wiesweg, Fabian Mairinger, Henning Reis, Annals of Oncology	2019	28
Combined multimodal ctDNA analysis and radiological imaging for tumor surveillance in Non-small cell lung cancer Martin Metzenmacher, Balázs Hegedűs, Jan Förster, Translational Oncology	2021	28
Prediction of malignant lymph nodes in NSCLC by machine-learning classifiers using EBUS-TBNA and PET/CT Maja Guberina, Ken Herrmann, Christoph Pöttgen, Scientific Reports	2022	20

Page 1